In my opinion galidisivir is the more attractive opportunity. Of course the best outcome would be a successful ISLA-101 trial and purchasing galidisivir, but if I had to choose only one I would choose galidisivir. Being able to gain FDA approval with just an animal study is very, very attractive.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.010(5.41%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.0¢ | $23.62K | 134.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11000 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 85485 | 1 |
View Market Depth
| Last trade - 12.32pm 16/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |